Search - tctmd.com

Displaying 261 - 280 of 639

Sort: Relevancy | Date

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Todd Neale

September 01, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Conference News ESC 2024

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

Todd Neale

August 30, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

Yael L. Maxwell

August 29, 2024

News Daily News

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Caitlin E. Cox

August 28, 2024

News Daily News

Appropriate Use Criteria Advise on Multimodality Imaging Before Noncardiac Surgery

Yael L. Maxwell

August 27, 2024

News Daily News

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Todd Neale

August 23, 2024

News Opinion Editor's Corner

What’s Going to Be Hot at ESC 2024

Shelley Wood

August 23, 2024

News Daily News

Going Contrast Free in TAVI Is Safe for CKD Patients

Caitlin E. Cox

August 20, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

Advertisement

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Appropriate Use Criteria Advise on Multimodality Imaging Before Noncardiac Surgery

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

What’s Going to Be Hot at ESC 2024

Going Contrast Free in TAVI Is Safe for CKD Patients

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content